Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacille Calmette-Guérin: 18-year experience
Authors:
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- RECURRENCE AND PROGRESSION OF STAGE T1, GRADE 3 TRANSITIONAL CELL CARCINOMA OF THE BLADDER FOLLOWING INTRAVESICAL IMMUNOTHERAPY WITH BACILLUS CALMETTE-GUERINJournal of Urology, 2000
- MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDYJournal of Urology, 2000
- Intravesical bacille Calmette-Guérin in stage T1 grade 3 bladder cancer therapy: a 7-year follow-upUrology, 1999
- Intravesical bacillus Calmette-Guérin treatment for Stage T1 grade 3 transitional cell carcinoma of the bladderUrology, 1998
- RELATIONSHIP AMONG CYSTECTOMY, MICROVESSEL DENSITY AND PROGNOSIS IN STAGE T1 TRANSITIONAL CELL CARCINOMA OF THE BLADDERJournal of Urology, 1998
- Low-Dose BCG Instillations in the Treatment of Stage T1 Grade 3 Bladder Tumours: Recurrence, Progression and SuccessEuropean Urology, 1998
- A 12 Versus 6-Week Course of Bacillus Calmette-Guerin Prophylaxis for the Treatment of High Risk Superficial Bladder CancerJournal of Urology, 1997
- Five-year results of a phase ii study with low-dose bacille calmette-guérin therapy in high-risk superficial bladder cancerUrology, 1995
- The efficacy of intravesical BCG in the treatment of patients with high risk superficial bladder cancerInternational Urology and Nephrology, 1991
- A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the BladderNew England Journal of Medicine, 1991